Andrew M. Oh - Sep 16, 2022 Form 3 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role
Director
Signature
/s/ Todd Rosenthal, as attorney-in-fact
Stock symbol
SYRS
Transactions as of
Sep 16, 2022
Transactions value $
$0
Form type
3
Date filed
9/19/2022, 05:06 PM
Next filing
Jun 2, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24: Power of Attorney